Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
The deal adds navtemadlin—a drug candidate for a rare blood cancer in late-stage clinical trials—to Ipsen’s oncology pipeline.
Connecting Global Economies
Flash News
Why Isn’t Carlos Alcaraz at Wimbledon 2026: Wrist Injury, Recovery
Is this World Cup now Europe v South America? Which giants fall today? Day 18 recap
Paris mortuaries overwhelmed as Europe’s record heat drives up death toll
Janet Jackson Surprise Arrival Makes Teyana Taylor Cry
Manchester United’s greatest players: No 23: Bill Foulkes
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
Nasa turns to robotic spacecraft to save telescope from falling back to Earth
AI data centers face heatwave and severe weather climate risks
Lauryn Hill Gets Tribute From Son Zion Marley, SZA, Lizzo
‘West Ham is my escape’: The fans who signed up for a season (at least) of Championship football
Monday, June 29, 2026